# SC IL-1Ra in SAH - Phase III Trial (SCIL)

> **NCT03249207** · PHASE3 · UNKNOWN · sponsor: **University of Manchester** · enrollment: 612 (actual)

## Conditions studied

- Subarachnoid Hemorrhage

## Interventions

- **DRUG:** IL-1Ra
- **DRUG:** IL-1Ra Placebo

## Key facts

- **NCT ID:** NCT03249207
- **Lead sponsor:** University of Manchester
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-11
- **Primary completion:** 2024-04
- **Final completion:** 2024-09
- **Target enrollment:** 612 (ACTUAL)
- **Last updated:** 2023-11-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03249207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03249207, "SC IL-1Ra in SAH - Phase III Trial (SCIL)". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03249207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*